Loading…
Disclosed for 93 months, Jan 2019 to Sep 2026.
quant Multi Cap Fund is an active equity fund in the Multi Cap category from quant Mutual Fund. In January 2021 it disclosed 35 stocks worth ₹165 Cr, up ₹31.6 Cr from Dec 2020. Its largest positions were Bharti Airtel Limited (8.4%), Fortis Healthcare Limited (7.9%), Oracle Financial Services Software Limited (6.9%); the ten largest together made up 53.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 18.8% of its equity. Cash and debt stood at 5.9%. Compared with Dec 2020 the fund entered 14 new stocks and exited 12.
Top-10 weight is higher than 100% of peers
Holds more stocks than 6% of peers
Holds more cash than 72% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Dec 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Bharti Airtel Limited | 8.38% | up 1.40 pts | ₹13.8 Cr | up ₹4.5 Cr | Added |
| Fortis Healthcare Limited | 7.85% | up 1.40 pts | ₹12.9 Cr | up ₹4.3 Cr | Added |
| Oracle Financial Services Software Limited | 6.89% | up 6.89 pts | ₹11.3 Cr | up ₹11.3 Cr | New |
| Stylam Industries Limited | 6.85% | down 1.70 pts | ₹11.3 Cr | down ₹10 L | Trimmed |
| Cash, TREPS & receivables | 5.87% | up 2.35 pts | ₹9.7 Cr | up ₹5 Cr | Added |
| Tech Mahindra Limited | 5.14% | up 5.14 pts | ₹8.5 Cr | up ₹8.5 Cr | New |
| Tata Steel Long Products Limited | 4.48% | up 2.04 pts | ₹7.4 Cr | up ₹4.1 Cr | Added |
| Sun Pharmaceutical Industries Limited | 4.18% | down 1.05 pts | ₹6.9 Cr | down ₹7 L | Trimmed |
| Bharat Rasayan Limited Bharat Rasayan Ltd. · history in this fund | 3.69% | up 0.71 pts | ₹6.1 Cr | up ₹2.1 Cr | Added |
| Infosys Limited | 3.16% | up 3.16 pts | ₹5.2 Cr | up ₹5.2 Cr | New |
| Vinati Organics Limited | 3.09% | up 3.09 pts | ₹5.1 Cr | up ₹5.1 Cr | New |
| Alembic Pharmaceuticals Limited | 3.08% | down 0.29 pts | ₹5.1 Cr | up ₹59 L | Added |
| Jubilant Pharmova Limited | 2.70% | up 0.47 pts | ₹4.5 Cr | up ₹1.5 Cr | Added |
| Divi's Laboratories Limited | 2.63% | down 1.08 pts | ₹4.3 Cr | down ₹61 L | Trimmed |
| Styrenix Performance Materials Limited | 2.53% | up 1.11 pts | ₹4.2 Cr | up ₹2.3 Cr | Added |
| ITC Limited | 2.48% | up 2.48 pts | ₹4.1 Cr | up ₹4.1 Cr | New |
| Deepak Fertilizers and Petrochemicals Corporation Limited | 2.45% | down 0.61 pts | ₹4 Cr | down ₹4 L | Trimmed |
| Reliance Industries Limited | 2.26% | up 2.26 pts | ₹3.7 Cr | up ₹3.7 Cr | New |
| India Financial Services Ltd | 2.18% | down 0.77 pts | ₹3.6 Cr | down ₹34 L | Trimmed |
| Dabur India Limited | 2.02% | down 0.57 pts | ₹3.3 Cr | down ₹13 L | Trimmed |
| Zydus Lifesciences Limited | 1.97% | down 0.61 pts | ₹3.3 Cr | down ₹18 L | Trimmed |
| Caplin Point Laboratories Limited | 1.90% | down 0.69 pts | ₹3.1 Cr | down ₹32 L | Trimmed |
| Strides Pharma Science Limited | 1.79% | down 0.60 pts | ₹3 Cr | down ₹23 L | Trimmed |
| Linde India Limited | 1.73% | down 0.57 pts | ₹2.9 Cr | down ₹21 L | Trimmed |
| UltraTech Cement Limited | 1.49% | up 1.49 pts | ₹2.5 Cr | up ₹2.5 Cr | New |
| Larsen & Toubro Limited | 1.34% | up 1.34 pts | ₹2.2 Cr | up ₹2.2 Cr | New |
| Neuland Laboratories Limited | 1.13% | down 0.06 pts | ₹1.9 Cr | up ₹28 L | Added |
| Kansai Nerolac Paints Limited | 1.07% | up 1.07 pts | ₹1.8 Cr | up ₹1.8 Cr | New |
| India Limited | 1.00% | up 0.33 pts | ₹1.6 Cr | up ₹76 L | Added |
| Kanchi Karpooram Limited | 0.78% | up 0.78 pts | ₹1.3 Cr | up ₹1.3 Cr | New |
| BASF India Limited | 0.76% | up 0.76 pts | ₹1.2 Cr | up ₹1.2 Cr | New |
| Grasim Industries Limited | 0.74% | up 0.74 pts | ₹1.2 Cr | up ₹1.2 Cr | New |
| Adani Ports and Special Economic Zone Limited | 0.69% | down 2.88 pts | ₹1.1 Cr | down ₹3.6 Cr | Trimmed |
| Aavas Financiers Limited | 0.65% | up 0.65 pts | ₹1.1 Cr | up ₹1.1 Cr | New |
| Dalmia Bharat Limited | 0.63% | up 0.63 pts | ₹1 Cr | up ₹1 Cr | New |
| Adani Enterprises Limited | 0.43% | down 2.87 pts | ₹71 L | down ₹3.7 Cr | Trimmed |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Dec 2020, the weight rose most in IT - Software (+13.8 pts) and Cement & Cement Products (+3.1 pts), and fell most in IT - Services (−7.6 pts) and Pharmaceuticals & Biotechnology (−4.1 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Jan 2020 | Jul 2020 | Oct 2020 | Dec 2020 | Jan 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 20.0% | 26.5% | 13.1% | 23.0% | 18.8% |
| IT - Software | — | — | 4.9% | 2.4% | 16.3% |
| Telecom - Services | — | 4.9% | 6.0% | 7.2% | 9.0% |
| Chemicals & Petrochemicals | — | 11.6% | 6.5% | 5.6% | 8.6% |
| Consumer Durables | — | 2.2% | 10.1% | 8.9% | 8.5% |
| Healthcare Services | — | — | — | 6.7% | 8.4% |
| Ferrous Metals | — | — | 3.3% | 4.8% | 4.8% |
| Pesticides | — | 2.6% | 4.6% | 3.1% | 3.9% |
| Cement & Cement Products | 9.3% | — | 6.7% | — | 3.1% |
| Finance | 12.9% | 3.1% | 4.7% | 3.1% | 3.0% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| Jun 2026 |
| ₹7,761 Cr |
| 47 |
| 3 |
| 4 |
| 5.8% |
| 10.0% |
| 289% |
| May 2026 | ₹7,664 Cr | 48 | 2 | 3 | 0.5% | 4.3% | 267% |
| Apr 2026 | ₹7,466 Cr | 49 | 1 | 3 | 0.2% | 4.1% | 271% |
| Mar 2026 | ₹6,574 Cr | 51 | 2 | 1 | 1.1% | 6.2% | 261% |
| Feb 2026 | ₹7,274 Cr | 50 | 6 | 3 | 6.6% | 12.0% | 258% |
| Jan 2026 | ₹7,456 Cr | 47 | 2 | 6 | 3.8% | 7.6% | 235% |
| Dec 2025 | ₹8,188 Cr | 51 | 3 | 3 | 0.4% | 4.4% | 214% |
| Nov 2025 | ₹8,804 Cr | 51 | 1 | 3 | 0.5% | 3.5% | 194% |
| Oct 2025 | ₹9,323 Cr | 53 | 4 | 3 | 2.1% | 4.8% | 179% |
| Sep 2025 | ₹9,240 Cr | 52 | 1 | 3 | 0.3% | 2.2% | 141% |
| Aug 2025 | ₹9,200 Cr | 54 | 2 | 7 | 3.4% | 5.9% | 147% |
| Jul 2025 | ₹9,632 Cr | 59 | 4 | 4 | 7.1% | 9.7% | 148% |
| Jun 2025 | ₹10,130 Cr | 59 | 4 | 3 | −1.7% | 0.8% | 156% |
| May 2025 | ₹9,927 Cr | 58 | 9 | 3 | −2.9% | 0.3% | 163% |
| Apr 2025 | ₹9,549 Cr | 52 | 3 | 3 | 2.1% | 5.9% | 164% |
| Mar 2025 | ₹9,389 Cr | 52 | 4 | 3 | 1.9% | 5.4% | 169% |
| Feb 2025 | ₹8,767 Cr | 51 | 1 | 6 | 5.5% | 7.2% | 168% |
| Jan 2025 | ₹9,863 Cr | 56 | 4 | 2 | 0.3% | 3.4% | 179% |
| Dec 2024 | ₹10,285 Cr | 54 | 3 | 2 | −0.1% | 2.3% | 186% |
| Nov 2024 | ₹10,614 Cr | 53 | 7 | 1 | −0.8% | 1.5% | 206% |
| Oct 2024 | ₹10,531 Cr | 47 | 2 | 0 | 6.0% | 7.0% | 232% |
For any of the 69 earlier months, choose it in “Portfolio as of” at the top of the page.